Bank of Montreal’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-468,900
| Closed | -$7.11K | – | 4564 |
|
|
2022
Q3 | $7.11K | Buy |
+468,900
| New | +$5.45M | ﹤0.01% | 1162 |
|
|
2021
Q4 | – | Sell |
-144,951
| Closed | -$1.66M | – | 3999 |
|
|
2021
Q3 | $1.66M | Buy |
144,951
+69,842
| +93% | +$1.02M | ﹤0.01% | 2181 |
|
|
2021
Q2 | $1.36M | Buy |
75,109
+74,096
| +7,315% | +$1.27M | ﹤0.01% | 2294 |
|
|
2021
Q1 | $19K | Sell |
1,013
-4,646
| -82% | -$80.2K | ﹤0.01% | 4094 |
|
|
2020
Q4 | $78K | Buy |
5,659
+3,958
| +233% | +$47.8K | ﹤0.01% | 3718 |
|
|
2020
Q3 | $20K | Sell |
1,701
-1,236
| -42% | -$15.1K | ﹤0.01% | 3848 |
|
|
2020
Q2 | $38K | Buy |
2,937
+2,399
| +446% | +$35.5K | ﹤0.01% | 3565 |
|
|
2020
Q1 | $7K | Sell |
538
-5,117
| -90% | -$97.1K | ﹤0.01% | 3617 |
|
|
2019
Q4 | $137K | Buy |
5,655
+786
| +16% | +$16.3K | ﹤0.01% | 3362 |
|
|
2019
Q3 | $93K | Buy |
4,869
+846
| +21% | +$19.4K | ﹤0.01% | 3345 |
|
|
2019
Q2 | $119K | Buy |
4,023
+3,350
| +498% | +$129K | ﹤0.01% | 3236 |
|
|
2019
Q1 | $32K | Sell |
673
-387
| -37% | -$17K | ﹤0.01% | 3518 |
|
|
2018
Q4 | $38K | Buy |
1,060
+304
| +40% | +$14.3K | ﹤0.01% | 3397 |
|
|
2018
Q3 | $47K | Sell |
756
-10
| -1% | -$643 | ﹤0.01% | 3423 |
|
|
2018
Q2 | $52K | Buy |
766
+253
| +49% | +$14.2K | ﹤0.01% | 3393 |
|
|
2018
Q1 | $28K | Hold |
513
| – | – | ﹤0.01% | 3456 |
|
|
2017
Q4 | $31K | Hold |
513
| – | – | ﹤0.01% | 3448 |
|
|
2017
Q3 | $25K | Hold |
513
| – | – | ﹤0.01% | 3452 |
|
|
2017
Q2 | $27K | Sell |
513
-235
| -31% | -$10.9K | ﹤0.01% | 3430 |
|
|
2017
Q1 | $34K | Hold |
748
| – | – | ﹤0.01% | 3207 |
|
|
2016
Q4 | $28K | Buy |
748
+382
| +104% | +$14.4K | ﹤0.01% | 3300 |
|
|
2016
Q3 | $14K | Buy |
+366
| New | +$8.07K | ﹤0.01% | 3475 |
|
|
2016
Q2 | – | Sell |
-998
| Closed | -$12K | – | 4391 |
|
|
2016
Q1 | $12K | Sell |
998
-18,361
| -95% | -$291K | ﹤0.01% | 3572 |
|
|
2015
Q4 | $471K | Buy |
+19,359
| New | +$452K | ﹤0.01% | 2020 |
|
|
2015
Q2 | – | Sell |
-116
| Closed | -$4K | – | 4169 |
|
|
2015
Q1 | $4K | Buy |
+116
| New | +$3.36K | ﹤0.01% | 3682 |
|
|
2014
Q3 | – | Sell |
-200
| Closed | -$5K | – | 4517 |
|
|
2014
Q2 | $5K | Buy |
+200
| New | +$3.46K | ﹤0.01% | 4190 |
|
Bank of Montreal's AERI Position: Q4 2022 in Review
Bank of Montreal sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 468,900 shares — an estimated $7.11K sold.
Bank of Montreal first reported a position in AERI in Q2 2014 and held it in 26 quarters. The position peaked at $1.66M in Q3 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Bank of Montreal reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Bank of Montreal sold 468,900 Aerie Pharmaceuticals shares in Q4 2022, an estimated $7.11K.
- Bank of Montreal first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 26 quarters.
- Bank of Montreal's Aerie Pharmaceuticals position peaked at $1.66M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.